Anetumab-MMAE, an ADC, combines a Mesothelin-targeting antibody with Monomethyl auristatin E (MMAE) and is employed in researching advanced pancreatic cancer.
Target:
Mesothelin|||ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted
